Speechmatics

Speechmatics develops AI-powered speech recognition and voice AI technology, providing speech APIs for speech-to-text, text-to-speech, and voice agent applications. The platform delivers low-latency, multilingual transcription across 56+ languages with multi-speaker conversation support, achieving sub-second speech-to-text processing. Its newly launched Melia model enables code-switching across languages, and its Medical Model achieves 98% accuracy for clinical transcription, cutting errors on key terms by up to 50%. The technology can be deployed on-device, on-premises, or in the cloud with no data logging as standard, making it suitable for privacy-critical use cases. Speechmatics serves diverse markets including MedTech, AI voice agents, media and broadcast captioning, contact center analytics, legal transcription, and meeting platforms. The company holds ISO 27001, GDPR, HIPAA, and SOC 2 Type II certifications. Customers include Adobe, LiveKit, AI Media, and Prosodica. Founded in 2006 and headquartered in Cambridge, United Kingdom, Speechmatics has raised approximately $90.6 million in Series B funding from investors including Susquehanna Growth Equity, AlbionVC, IQ Capital, Amadeus Capital, In-Q-Tel, and Microsoft Accelerator.